John Marsden

Professor of Addiction Psychology

King’s College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

John Marsden is a Professor of Addiction Psychology at King's College London in the UK. His research focuses on opioid use disorder, psychedelic-assisted treatments, and the barriers and facilitators to implementing patient-reported outcome measures in addiction treatment. His recent publications include studies on regulatory policies for psychedelics, alcohol use among individuals with autism spectrum disorder, and the cost-effectiveness of employment support models for people with substance dependence.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Luke Clark

Associate Professor

The University of British Columbia

CANADA

View details

Jason Connor

Professor

University of Queensland

AUSTRALIA

View details

THERESA HYDES

University of Southampton

UNITED KINGDOM

View details

David A. Fiellin

UNITED STATES

View details

Briony Larance

University of Wollongong

AUSTRALIA

View details

Ed Day

King’s College London

UNITED KINGDOM

View details

Jamie Brown

University College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

John Marsden

Research Interests

Explore related searches

Contact this professor

About

Articles (21)

A mixed‐methods study of staff perspectives on the barriers and facilitators to the implementation of patient‐reported routine outcome measures and feedback in alcohol and other drug treatment

Routine outcome monitoring and feedback in alcohol and other drug treatment: A qualitative study of client perspectives on implementation

Extended-release buprenorphine treatment for opioid use disorder

Disentangling debate about therapeutic and recreational use of psychedelics

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

Alcohol use among populations with autism spectrum disorder: narrative systematic review

The independent and joint risks of alcohol consumption, smoking, and excess weight on morbidity and mortality: a systematic review and meta-analysis exploring synergistic associations

Crafting effective regulatory policies for psychedelics: What can be learned from the case of cannabis?

Superiority and cost-effectiveness of Individual Placement and Support versus standard employment support for people with alcohol and drug dependence: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial

Patient experience of opioid use disorder treatment medications: a systematic review of contemporary qualitative research

How Addiction handles disagreements over potentially harmful terminology

Patients’ perceptions of self-administered dosing to opioid agonist treatment and other changes during the COVID-19 pandemic: a qualitative study

Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication

The impact of the COVID‐19 pandemic on addictive disorders—an update

Extended-release pharmacotherapy for opioid use disorder (EXPO)

Experience and response to a randomised controlled trial of extended-release injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone for opioid use disorder

Addiction is moving online‐only in 2023

The opioid use disorder core outcomes set (OUD–COS) for treatment research: findings from a Delphi consensus study

Responding to 100 000 annual drug overdose deaths in the United States: a special section of commentaries

Synthesizing advice to the United States from other nations that have experienced drug epidemics

Pre‐registration: not a daunting practice

Collaborators (7)

Luke Clark

Jason Connor

THERESA HYDES

David A. Fiellin

Briony Larance

Ed Day

Jamie Brown

Make your next move.